Department of Health
and Human Services (HHS)
and Human Services (HHS)
February 4, 2021
NOT-OD-22-215 - NIH Final Federal Financial Reports (FFRs) will no longer be converted to Interim Annual Reports in the Payment Management System
NOT-OD-22-099- Upcoming Changes to the Federal Financial Report (FFR) Beginning April 1, 2022
NOT-OD-21-128 - Updated Process for Submission of Federal Financial Reports for Closed Payment Management System Subaccounts
NOT-OD-21-046 - Reminder: Mandatory Submission of the Federal Financial Report (FFR) in the Payment Management System Beginning January 1, 2021
NOT-OD-20-127 - Upcoming Mandatory Submission of the Federal Financial Report (FFR) in the Payment Management System Beginning January 1, 2021
NOT-OD-21-138 - NIH Final Federal Financial Reports (FFRs) will be converted to Interim Annual Reports in the Payment Management System
NATIONAL INSTITUTES OF HEALTH (NIH)
The purpose of this Notice is to acknowledge challenges that recipients have experienced with submitting the SF-425 Federal Financial Report (FFR) via a single-entry point in the HHS Payment Management System (PMS). The requirement went into effect on January 1, 2021.
Recipients have reported a significant increase in errors in submitting reports via a single-entry point. The errors are mainly caused because the system does not allow recipients to submit reports that do not reconcile expenditure versus quarterly cash transaction data. When the data does not reconcile, the HHS PMS will not accept the reports. These challenges have begun to create delays in reporting and certifying expenditure FFRs as required by the terms and conditions of the awards. NIH and its eRA partners recognize this has impacted recipients ability to submit timely final FFRs in accordance with established deadlines outlined in the terms and conditions of award.
Given the significant impact, agencies will provide leniency, as appropriate, where these challenges prevent recipients from submitting timely FFRs. Recipients are required to notify their Grants Management Official of these unavoidable delays and retain all documentation related to this flexibility in the event of an audit finding. Any delays other than the PMS reconciliation issues identified in this notice are not covered under this flexibility.
NIH and its partners are working closely with HHS PMS to address this matter as quickly as possible, and will continue to provide updates, as available.
NIH:
Office of Policy for Extramural Research Administration
Systems Policy Branch
AHRQ:
Division of Grants Management
FDA:
Food and Drug Administration (FDA)
Office of Acquisitions and Grants Services (OAGS)
Grants Management Branch
Email:OAGSGrantsPolicy@fda.hhs.gov